GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paul Hartmann AG (FRA:PHH2) » Definitions » Debt-to-Revenue

Paul Hartmann AG (FRA:PHH2) Debt-to-Revenue : 0.10 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Paul Hartmann AG Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Paul Hartmann AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €39 Mil. Paul Hartmann AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €204 Mil. Paul Hartmann AG's annualized Revenue for the quarter that ended in Dec. 2023 was €2,376 Mil. Paul Hartmann AG's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.10.


Paul Hartmann AG Debt-to-Revenue Historical Data

The historical data trend for Paul Hartmann AG's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paul Hartmann AG Debt-to-Revenue Chart

Paul Hartmann AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.03 0.03 0.11 0.10

Paul Hartmann AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - 0.11 - 0.10

Competitive Comparison of Paul Hartmann AG's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paul Hartmann AG's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Paul Hartmann AG's Debt-to-Revenue falls into.



Paul Hartmann AG Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Paul Hartmann AG's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(39.349 + 203.96) / 2353.262
=0.10

Paul Hartmann AG's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(39.349 + 203.96) / 2376.016
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.


Paul Hartmann AG Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Paul Hartmann AG's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Paul Hartmann AG (FRA:PHH2) Business Description

Traded in Other Exchanges
Address
Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
Executives
Eduard Schleicher Supervisory Board
Britta Fünfstück Board of Directors

Paul Hartmann AG (FRA:PHH2) Headlines

No Headlines